Literature DB >> 10459399

Tryptophan depletion and depressive vulnerability.

F A Moreno1, A J Gelenberg, G R Heninger, R L Potter, K M McKnight, J Allen, A P Phillips, P L Delgado.   

Abstract

BACKGROUND: Rapid and transient depletion of tryptophan (TRP) causes a brief depressive relapse in most patients successfully treated with and taking selective serotonin reuptake inhibitors, but little change in drug-free, symptomatic depressed patients. This study investigates the effects of TRP depletion in drug-free subjects in clinical remission from a prior major depressive episode (MDE).
METHODS: Twelve subjects with a prior MDE, currently in clinical remission and drug-free for at least 3 months (patients), and 12 healthy subjects without personal or family history of Axis I disorder (controls), received TRP depletion. The study was conducted in a double-blind, controlled [full (102-g) and quarter-strength (25 g) 15-amino acid drinks], crossover fashion. Behavioral ratings and plasma TRP levels were obtained prior to, during, and after testing.
RESULTS: All subjects experienced significant depletion of plasma TRP on both test-drinks, showing a significant dose-response relation. Healthy control subjects had minimal mood changes, but patients had a depressive response of greater magnitude.
CONCLUSIONS: In the context of prior TRP depletion studies with antidepressant-treated, and drug-free symptomatic depressed patients, these results suggest that depression may be caused not by an abnormality of 5-HT function, but by dysfunction of other systems or brain regions modulated by 5-HT.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10459399     DOI: 10.1016/s0006-3223(99)00095-5

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  25 in total

1.  Can serotonin transporter genotype predict craving in alcoholism?

Authors:  Nassima Ait-Daoud; John D Roache; Michael A Dawes; Lei Liu; Xin-Qun Wang; Martin A Javors; Chamindi Seneviratne; Bankole A Johnson
Journal:  Alcohol Clin Exp Res       Date:  2009-05-04       Impact factor: 3.455

2.  CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls.

Authors:  Francisco A Moreno; Damian Parkinson; Craig Palmer; Wm Lesley Castro; John Misiaszek; Aram El Khoury; Aleksander A Mathé; Ron Wright; Pedro L Delgado
Journal:  Eur Neuropsychopharmacol       Date:  2010-01       Impact factor: 4.600

3.  Alteration of frontal EEG asymmetry during tryptophan depletion predicts future depression.

Authors:  John J B Allen; Katherine M McKnight; Francisco A Moreno; Heath A Demaree; Pedro L Delgado
Journal:  J Affect Disord       Date:  2008-09-18       Impact factor: 4.839

Review 4.  Biological risk factors for late life depression.

Authors:  Henning Tiemeier
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 5.  Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression.

Authors:  Charles S Carver; Sheri L Johnson; Jutta Joormann
Journal:  Psychol Bull       Date:  2008-11       Impact factor: 17.737

Review 6.  Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter.

Authors:  Alexander Neumeister; Theresa Young; Juergen Stastny
Journal:  Psychopharmacology (Berl)       Date:  2004-07-13       Impact factor: 4.530

7.  Serotonin 5-HT1A receptors modulate depression-related symptoms following mild traumatic brain injury in male adult mice.

Authors:  Morteza Kosari-Nasab; Ghaffar Shokouhi; Maryam Azarfarin; Maryam Bannazadeh Amirkhiz; Mehran Mesgari Abbasi; Ali-Akbar Salari
Journal:  Metab Brain Dis       Date:  2019-01-03       Impact factor: 3.584

8.  Sex-based changes in rat brain serotonin and behavior in a model of altitude-related vulnerability to treatment-resistant depression.

Authors:  Shami Kanekar; Chandni Sheth; Hendrick Ombach; Jadeda Brown; Michael Hoffman; Robert Ettaro; Perry Renshaw
Journal:  Psychopharmacology (Berl)       Date:  2021-06-22       Impact factor: 4.530

Review 9.  Oscillatory serotonin function in depression.

Authors:  Ronald M Salomon; Ronald L Cowan
Journal:  Synapse       Date:  2013-05-21       Impact factor: 2.562

10.  Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response.

Authors:  Pierre Blier; Gabriella Gobbi; Nasser Haddjeri; Luca Santarelli; Gina Mathew; René Hen
Journal:  J Psychiatry Neurosci       Date:  2004-05       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.